Clonoseq testing for VISN 1
Ended Awarded Last action
- Contract number
- 36C24125N0234
- Awardee
-
Adaptive Biotechnologies Corporation UEI DMW5BNQ331K9
- Awarding agency
-
Veterans Integrated Service Network 1
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $5,850
Award facts
- Contract value 100% obligated
- $5,850.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- West Haven, CT 06516, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$150 | |
| Original award | $6,000 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 1 (VISN 1) awarded a contract call to Adaptive Biotechnologies Corporation valued at $5,850.00 for ClonoSEQ testing services, with an ultimate completion date of July 14, 2025. This award is issued as a Blanket Purchase Agreement (BPA) call under Adaptive's existing single-award BPA with VISN 1, valued at $828,750 with a five-year ordering period through July 2027. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating open competition. Services will be performed at the VA Medical Center in West Haven, Connecticut.
Adaptive Biotechnologies Corporation, headquartered in Seattle, Washington, specializes in immunosequencing and minimal residual disease testing through advanced genomic sequencing technologies. ClonoSEQ testing is a sophisticated diagnostic service used to detect and monitor clonal populations of immune cells, supporting clinical diagnostics and research missions across the VA healthcare system. Under the existing VISN 1 BPA, Adaptive has received multiple call orders totaling over $330,000 for testing services at VA facilities across New England and other locations. This award includes a deobligation of $150.00 in excess funds, reflecting contract management adjustments to the overall BPA.
Quick answers
Who was awarded contract 36C24125N0234?
36C24125N0234 was awarded to Adaptive Biotechnologies Corporation by Veterans Integrated Service Network 1 (Veterans Health Administration) on December 6, 2024.
How much is contract 36C24125N0234 worth?
The government has obligated $5,850 on 36C24125N0234.
Is contract 36C24125N0234 an order under another contract?
Yes. 36C24125N0234 is a BPA call under 36C24122A0124, a blanket purchase agreement.
Was contract 36C24125N0234 competed?
The extent of competition for 36C24125N0234 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award